TY - JOUR
T1 - The clinical utility of tumor markers
AU - Handy, Beverly
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2009
Y1 - 2009
N2 - Tumor markers provide a minimally invasive, cost-effective source of data valuable for monitoring disease course, determining prognosis, and aiding in treatment planning. An understanding of the individual test characteristics and limitations, however, is important for optimal use and accurate interpretation of results. A variety of types of markers are available in the routine clinical laboratory including enzymes, oncofetal antigens, oncogene products, monoclonal antibody-defined epitopes, and hormones. The clinical applications and limitations of some that are currently in widespread use will be discussed.
AB - Tumor markers provide a minimally invasive, cost-effective source of data valuable for monitoring disease course, determining prognosis, and aiding in treatment planning. An understanding of the individual test characteristics and limitations, however, is important for optimal use and accurate interpretation of results. A variety of types of markers are available in the routine clinical laboratory including enzymes, oncofetal antigens, oncogene products, monoclonal antibody-defined epitopes, and hormones. The clinical applications and limitations of some that are currently in widespread use will be discussed.
UR - http://www.scopus.com/inward/record.url?scp=77956954954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956954954&partnerID=8YFLogxK
U2 - 10.1309/LMTRKSKYW4GI6SBJ
DO - 10.1309/LMTRKSKYW4GI6SBJ
M3 - Review article
AN - SCOPUS:77956954954
SN - 0007-5027
VL - 40
SP - 99
EP - 103
JO - Laboratory Medicine
JF - Laboratory Medicine
IS - 2
ER -